Bioavailability and bioequivalence in pharmaceutical technology / (Record no. 6245)

MARC details
000 -LEADER
fixed length control field 01642nam a2200217Ia 4500
003 - CONTROL NUMBER IDENTIFIER
control field NULRC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250520094922.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 250520s9999 xx 000 0 und d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 8123911580
040 ## - CATALOGING SOURCE
Transcribing agency NULRC
050 ## - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS 192 .B56 2004
245 #0 - TITLE STATEMENT
Title Bioavailability and bioequivalence in pharmaceutical technology /
Statement of responsibility, etc. edited by Tapan Kumar Pal and M. Ganesan
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. New Delhi, India :
Name of publisher, distributor, etc. CBS Publishers & Distributors,
Date of publication, distribution, etc. c2004
300 ## - PHYSICAL DESCRIPTION
Extent viii, 159 pages :
Other physical details illustrations ;
Dimensions 25 cm.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Ethical issues involved in Bioequivalence study -- Understanding bioavailability -- Bioavailability studies in man: pharmacokinetic considerations -- Method of sample preparation and HPLC analysis of some common drugs from biological fluids -- Application of HPLC for analysis of biological samples and drugs -- Microdialysis and its application in bioavailability studies -- Ocular kinetics and drug delivery systems of ophthalmic medicines- a review -- Bioequivalence study and data interpretation -- Introduction to bio-analytical method development and validation for bioavailability and bio-equivalence studies -- High performance liquid chromatography, an upgraded technology for the monitoring of therapeutic drugs -- Systematic clinical and toxicological analysis using solid phase extraction -- Bioequivalence of Gatifloxacin by HPLC method- a case study
520 ## - SUMMARY, ETC.
Summary, etc. Proceedings of the Seminar-cum-Workshop on Bioavailability and Bioequivalence.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element DRUGS BIOAVAILABILITY
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Pal, Tapan Kumar;Ganesan, M.
Relator term editor;editor
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Library of Congress Classification
Koha item type Books
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Source of acquisition Total checkouts Full call number Barcode Date last seen Copy number Price effective from Koha item type
    Library of Congress Classification     Pharmacy LRC - Main National University - Manila General Circulation 03/16/2012 Reaccessioned   GC RS 192 .B56 2004 NULIB000004004 05/20/2025 c.1 05/20/2025 Books